AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Feb 19, 2025
31676_dirs_2025-02-18_471b5ead-4ab9-4486-bc22-690214cfca8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-02-12
Reporting Person: CAREY STEPHEN P. (SVP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-12 | Common Stock | A | 24808 | — | Acquired | 179276 | Direct |
| 2025-02-12 | Common Stock | A | 16538 | — | Acquired | 195814 | Direct |
| 2025-02-14 | Common Stock | F | 1730 | $58.92 | Disposed | 194084 | Direct |
Footnotes
F1: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
F2: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
F3: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported.